HL-ExoI is a 3’-5’ exonuclease, specific for single stranded DNA. HL-ExoI is active at temperatures ≥25°C, and inactivated by 1 min incubation at 80°C, or 15 min at 60°C


Source: Recombinantly produced in an E. coli strain expressing the HL-ExoI gene originating from an Arctic marine bacterium.

Unit Definition: One unit catalyses the release of 10 nmol of acid soluble nucleotides in 30 min at 25°C. Reaction buffer: 20 mM Tris-HCl pH 7.5 at 25°C, 200 mM NaCl, 20 mM MgCl2, 1 mM DTT, 0.01% Triton X-100, 2.5% glycerol and 3H-dATP-labelled DNA (25 ng/µl).

Optimal reaction conditions: 0-15 mM MgCl2 and ≤100 mM NaCl, at 25-37°C.

Quality Control

ArcticZymes is dedicated to the quality of our products. We manufacture all our products at our ISO 13485 certified facility in Norway

ssDNA endonuclease activity: 100 U HL-ExoI was incubated with M13 ssDNA (0.5 μg) for 4 hours at 37°C. Agarose gel electrophoresis did not reveal any visible signs of ssDNA degradation.

dsDNA endonuclease activity: 200 U HL-ExoI was incubated with a supercoiled plasmid (1 μg) for 4 hours at 37°C. Agarose gel electrophoresis did not reveal any transformation of closed circular DNA to nicked DNA.

Additional Data and Information

We are pleased to provide additional data relating to T4 DNA Ligase upon request.

We appreciate suggestions for product modifications.

Storage and Stability

The enzyme is stable at -20°C for 3 years in the supplied storage buffer. The enzyme tolerates at least five freeze-thaw cycles (-80°C) without loss of activity.

Disclaimer: These products are intended for research use only. Certain applications of ArcticZymes AS products may require licenses from others. It is the expressed duty of any receiver of ArcticZymes AS products to acquire such licenses, if necessary. To the extent allowed by law, ArcticZymes AS will not be liable for damages, whether direct, indirect, incidental, or consequential in connection with or arising from this document, including the use of it. ArcticZymes AS products may be covered by pending or issued patents, designs or design applications and/or trademarks or trademark applications or any other registered or unregistered Intellectual Property Right..